Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bio Reports 2-Percent Increase in Q4 Revenues, Earnings Shortfall

NEW YORK, March 9 (GenomeWeb News) - Harvard Bioscience yesterday reported a slight increase in revenues but a cut in earnings for the fourth quarter of 2004.


The company booked $24.7 million in revenues for the quarter, up 2 percent from $24.2 million during the same quarter in 2003.


R&D expenses amounted to $1.9 million for the quarter, up from $1.6 million for the same period a year ago.


HBIO's net income for the quarter was $1.1 million, or $.04 per share, down from $1.8 million, or $.06 per share, during the year-ago quarter. However, for the full year 2004, earnings fell by nearly half to $2.3 million, or $.08 per share, from $4.3 million, or $.14 per share, year over year. The primary cause for this decline was a shortfall in revenues at HBIO's Genomic Solutions subsidiary, CEO Chane Graziano said in a statement.


"However, we believe that we have turned the corner," he said. "In looking forward to 2005, we remain encouraged by the improved performance at Genomic Solutions for the fourth quarter, the strong performance of our recent acquisitions and continued strengthening in the life sciences market."


As of Dec. 31, 2004, HBIO had $13.9 million in cash and cash equivalents.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.